Peyman Hadji

Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial

Jacques P. Brown, Richard L. Prince, Chad Deal et al. · Journal of Bone and Mineral Research · 2008 · 595 citations

Total Hip, Gynecology, Pharmacotherapy +16

Bone health in cancer patients: ESMO Clinical Practice Guidelines

Robert E. Coleman, Jean‐Jacques Body, Matti Aapro et al. · Annals of Oncology · 2014 · 554 citations · Full text

Bone Disease, Bone Health, Medicine +6

Bone health in cancer: ESMO Clinical Practice Guidelines

Robert E. Coleman, Peyman Hadji, Jean‐Jacques Body et al. · Annals of Oncology · 2020 · 481 citations · Full text

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

Cornelis JH van de Velde, Daniel Rea, Caroline Seynaeve et al. · The Lancet · 2011 · 375 citations

Breast Oncology, Oncology, Early Breast Cancer +9

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer

Volker Ziller, Matthias Kalder, Ute‐Susann Albert et al. · Annals of Oncology · 2009 · 258 citations · Full text

Breast Oncology, Medicine, Gynecology +9